Mapping the number of female sex workers in countries across sub-Saharan Africa.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
10 01 2023
Historique:
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: ppublish

Résumé

Female sex workers (FSW) are affected by individual, network, and structural risks, making them vulnerable to poor health and well-being. HIV prevention strategies and local community-based programs can rely on estimates of the number of FSW to plan and implement differentiated HIV prevention and treatment services. However, there are limited systematic assessments of the number of FSW in countries across sub-Saharan Africa to facilitate the identification of prevention and treatment gaps. Here we provide estimated population sizes of FSW and the corresponding uncertainties for almost all sub-national areas in sub-Saharan Africa. We first performed a literature review of FSW size estimates and then developed a Bayesian hierarchical model to synthesize these size estimates, resolving competing size estimates in the same area and producing estimates in areas without any data. We estimated that there are 2.5 million (95% uncertainty interval 1.9 to 3.1) FSW aged 15 to 49 in sub-Saharan Africa. This represents a proportion as percent of all women of childbearing age of 1.1% (95% uncertainty interval 0.8 to 1.3%). The analyses further revealed substantial differences between the proportions of FSW among adult females at the sub-national level and studied the relationship between these heterogeneities and many predictors. Ultimately, achieving the vision of no new HIV infections by 2030 necessitates dramatic improvements in our delivery of evidence-based services for sex workers across sub-Saharan Africa.

Identifiants

pubmed: 36595685
doi: 10.1073/pnas.2200633120
pmc: PMC9926247
doi:

Types de publication

Review Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200633120

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH129226
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136664
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI170249
Pays : United States

Références

J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):148-155
pubmed: 32639275
Curr Opin HIV AIDS. 2014 Mar;9(2):115-25
pubmed: 24356328
Curr Opin HIV AIDS. 2014 Mar;9(2):95-100
pubmed: 24499807
Nat Commun. 2020 Feb 18;11(1):773
pubmed: 32071298
Lancet. 2015 Jan 3;385(9962):4-7
pubmed: 25059948
Lancet. 2015 Jan 10;385(9963):172-85
pubmed: 25059938
J Int AIDS Soc. 2013 Dec 02;16 Suppl 3:18751
pubmed: 24321113
Lancet. 2015 Jan 10;385(9963):186-99
pubmed: 25059943
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
AIDS Behav. 2020 Mar;24(3):714-723
pubmed: 31041624
AIDS Behav. 2018 Apr;22(4):1113-1121
pubmed: 29159593
Curr Opin HIV AIDS. 2014 Mar;9(2):107-14
pubmed: 24393694
Syst Rev. 2018 Dec 3;7(1):220
pubmed: 30509317
Stud Fam Plann. 2015 Mar;46(1):55-71
pubmed: 25753059
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
Lancet. 2015 Jan 10;385(9963):97-9
pubmed: 25059951
J Fam Plann Reprod Health Care. 2015 Apr;41(2):102-8
pubmed: 25056256
Lancet. 2015 Jan 10;385(9963):94-6
pubmed: 25059945
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S83-90
pubmed: 25723995
Syst Rev. 2020 Nov 24;9(1):266
pubmed: 33234162
PLoS One. 2020 Feb 26;15(2):e0228634
pubmed: 32101551
Curr Opin HIV AIDS. 2014 Sep;9(5):506-13
pubmed: 25010898

Auteurs

Ian Laga (I)

Montana State University, Bozeman, MT 59717.

Xiaoyue Niu (X)

Pennsylvania State University, University Park, PA 16802.

Katherine Rucinski (K)

Johns Hopkins University, Baltimore, MD 21205.

Stefan Baral (S)

Johns Hopkins University, Baltimore, MD 21205.

Amrita Rao (A)

Johns Hopkins University, Baltimore, MD 21205.

David Chen (D)

Pennsylvania State University, University Park, PA 16802.

Nikita Viswasam (N)

University of Maryland, College Park, MD 20742.

Nancy Refilwe Phaswana-Mafuya (NR)

South African Medical Research Council/University of Johannesburg Pan African Centre for Epidemics Research Extramural Unit and Faculty of Health Sciences, University of Johannesburg, Johannesburg 2028, South Africa.

Daouda Diouf (D)

Enda Santé, Dakar 3370, Senegal.

Keith Sabin (K)

The Joint United Nations Programme on HIV/AIDS, Geneva 1211, Switzerland.

Jinkou Zhao (J)

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva 1218, Switzerland.

Jeffrey W Eaton (JW)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London SW7 2AZ, UK.

Le Bao (L)

Pennsylvania State University, University Park, PA 16802.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH